Citation Impact
Citing Papers
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
2017
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
2012 Standout
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
2016 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure
2015
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Burden of liver diseases in the world
2018 Standout
Diagnostic criteria for malnutrition – An ESPEN Consensus Statement
2015 Standout
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Gut biogeography of the bacterial microbiota
2015 Standout
Spontaneous bacterial peritonitis: recent guidelines and beyond
2011
Acute-on chronic liver failure
2012
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
2011
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance
2019 Standout
Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation
2014
The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus
2013
The effect of fatigue on multifinger co‐ordination in force production tasks in humans
2000
The challenges of multi-drug-resistance in hepatology
2016
Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
2014
Global burden of liver disease: 2023 update
2023 Standout
Frailty: implications for clinical practice and public health
2019 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Acute on Chronic Liver Failure—What is in a ‘Definition’?
2016
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis
2013
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Clinical Consequences of Infection in Cirrhosis: Organ Failures and Acute‐on‐Chronic Liver Failure
2019
The clinical spectrum of pulmonary aspergillosis
2014
Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
2011
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
2012
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Risk factor of community‐onset spontaneous bacterial peritonitis caused by fluoroquinolone‐resistant Escherichia coli in patients with cirrhosis
2013
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial
2015
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Relationship between the Viable but Nonculturable State and Antibiotic Persister Cells
2018
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Infections complicating cirrhosis
2018
Both sarcopenia and frailty determine suitability of patients for liver transplantation—A systematic review and meta‐analysis of the literature
2018
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Antibiotic resistance in healthcare‐related and nosocomial spontaneous bacterial peritonitis
2016
Works of C. Lucidi being referenced
An empirical broad spectrum antibiotic therapy in health‐care–associated infections improves survival in patients with cirrhosis: A randomized trial
2015
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
2014
Increased risk of cognitive impairment in cirrhotic patients with bacterial infections
2013
Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections
2010
Sarcopenia in liver cirrhosis
2015
Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study
2012
Presence of multiple bacterial markers in clinical samples might be useful for presumptive diagnosis of infection in cirrhotic patients with culture-negative reports
2016
The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey
2015
P473 BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: RISK FACTORS AND RATE OF FAILURE OF THE EMPIRICAL ANTIBIOTIC THERAPY
2014
Adaptation to fatigue of long duration in human wrist movements
1992
The chronic use of beta‐blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis
2014